Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.71T | 1.64T | 1.69T | 1.81T | 1.63T | 1.53T | Gross Profit |
682.07B | 636.80B | 675.85B | 768.23B | 622.20B | 581.46B | EBIT |
278.65B | 261.10B | 297.89B | 424.06B | 313.24B | 253.25B | EBITDA |
434.78B | 418.49B | 473.47B | 588.60B | 459.88B | 394.81B | Net Income Common Stockholders |
186.00B | 180.84B | 243.95B | 314.12B | 237.06B | 183.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
571.70B | 622.01B | 493.25B | 568.44B | 450.80B | 376.16B | Total Assets |
2.97T | 3.04T | 2.87T | 2.81T | 2.46T | 2.25T | Total Debt |
53.99B | 105.94B | 151.00B | 142.98B | 175.75B | 236.07B | Net Debt |
-517.71B | -516.07B | -167.56B | -227.41B | -188.22B | -3.59B | Total Liabilities |
422.49B | 482.29B | 470.29B | 545.26B | 540.62B | 555.42B | Stockholders Equity |
2.55T | 2.56T | 2.26T | 2.26T | 1.92T | 1.69T |
Cash Flow | Free Cash Flow | ||||
311.41B | 253.41B | 86.33B | 270.93B | 173.69B | 64.40B | Operating Cash Flow |
522.90B | 489.64B | 276.28B | 421.46B | 373.57B | 350.33B | Investing Cash Flow |
-192.70B | -214.34B | -157.85B | -212.30B | -150.28B | -284.43B | Financing Cash Flow |
-267.60B | -165.32B | -173.71B | -117.50B | -118.19B | 17.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $38.76B | 26.52 | 19.04% | 1.49% | 18.08% | 7.28% | |
78 Outperform | $48.22B | 35.64 | 11.33% | 1.75% | 1.23% | -58.22% | |
78 Outperform | $27.23B | 37.15 | 14.30% | ― | -1.16% | -7.04% | |
74 Outperform | $23.60B | 30.48 | 7.70% | 0.46% | 0.85% | -10.01% | |
72 Outperform | $26.34B | 17.60 | 8.98% | 1.45% | 0.94% | 23.04% | |
64 Neutral | $42.48B | 94.91 | 4.14% | 2.26% | 9.77% | -26.50% | |
62 Neutral | $11.80B | 10.08 | -7.46% | 2.99% | 7.37% | -8.21% |